The NXTGEN HIGHTECH program drives the development and standardization of organ-on-a-chip technology. The Dutch consortium brings together more than 330 parties from industry and knowledge institutes to advance a range of next-generation technologies and to establish scalable, viable market pipelines.
The aim of organ-on-a-chip technology is to mimic human physiology, presenting a biologically relevant in vitro testing environment which maintains tissue-specific functions. In this way, it is possible to facilitate early in vitro testing of how a therapeutic might affect human cells with a functional readout.
Dear Readers, The Skinobs team would like to apologise sincerely to Faiza Hussain, Co-Founder and…
Acheless is an essential wearable device for modern society, where digital living is commonplace. To…
Linking consumer data with sensory data is an essential step in formulating products that accurately…